Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Stable Angina Pectoris | Research article

Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study

Authors: Han Yin, Yuting Liu, Huan Ma, Guihao Liu, Lan Guo, Qingshan Geng

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

Depression and anxiety are prevalent and associated with a worse prognosis in coronary heart disease (CHD) patients. However, the influence of disease severity on mood symptoms is unknown. The specific associations of mood symptoms with NYHA classes remain unexplored.

Methods

In this cross-sectional study, 443 consecutive inpatients with angina pectoris (AP) confirmed by angiography were included into analysis. Somatic and cognitive symptom scores derived from Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Scale (GAD-7) were used to assess mood symptoms. Predictors for depression and anxiety with strict and lax standards were compared. We hypothesized NYHA classification to be an indicator of disease severity through analyses with clinical features using ordinal logistic model. Applying both binary and ordinal logistic models, we evaluated the associations of mood symptoms with NYHA classes.

Results

Discrepancy of disease severity existed between the depressed and nondepressed. NYHA classification was proved to be an integrated index under influence of age, coronary stenosis, heart failure and diabetes. NYHA class I and II individuals with AP were at equivalent risk for depression (NYHA II vs I: binary model OR 1.32 (0.59,2.96), p = 0.50; ordinal model OR 1.17 (0.73,1.88), p = 0.52), however NYHA class III/IV patients shared a sharply higher risk (NYHA III/IV vs I: binary model OR 3.32 (1.28,8.61), p = .013; ordinal model OR 3.94 (2.11,7.36), p < .001). Analyses on somatic and cognitive depressive symptoms confirmed this finding and hinted a greater impact of education background on mood when patient’s condition is unstable. Anxiety seemed in the whole picture irrelevant with NYHA classes. Comparing with NYHA class I/II, AP patients in NYHA class III/IV tended to be less anxious. However, when CHD became unstable, the calmness may immediately be broken up. A great distinction of the ratio of anxiety and depression symptom scores between NYHA class III/IV stable and unstable AP patients (p = .018) was observed.

Conclusions

Mood symptoms in CHD patients are to a great extend derived from disease itself. Only for patients with relatively serious physical condition, unexpected discomforts caused by disease notably impact the emotions. Education background tends to influence the mood especially when disease is still unstable.
Appendix
Available only for authorised users
Literature
1.
Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol. 2017;14(3):145–55.PubMed
2.
Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46.PubMed
3.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasuresmith N, Freedland KE, Jaffe AS, Leifheitlimson EC, Sheps DS. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69.PubMed
4.
Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol. 2007;49(20):2021–7.PubMed
5.
Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney RM, Denollet J, Doyle F, Freedland KE, Grace SL, Hosseini SH, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. The British journal of psychiatry : the journal of mental science. 2013;203(2):90–102.
6.
Adelborg K, Schmidt M, Sundboll J, Pedersen L, Videbech P, Botker HE, Egstrup K, Sorensen HT. Mortality risk among heart failure patients with depression: a Nationwide population-based cohort study. J Am Heart Assoc. 2016;5(9).
7.
Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J. 2015;170(6):1105–15.PubMedPubMedCentral
8.
Lett H, Ali S, Whooley M. Depression and cardiac function in patients with stable coronary heart disease: findings from the heart and soul study. Psychosom Med. 2008;70(4):444–9.PubMedPubMedCentral
9.
Lane D, Ring C, Lip GY, Carroll D. Depression, indirect clinical markers of cardiac disease severity. and mortality following myocardial infarction Heart (British Cardiac Society). 2005;91(4):531–2.
10.
Carroll D, Lane D. Depression and mortality following myocardial infarction: the issue of disease severity. Epidemiologia e psichiatria sociale. 2002;11(2):65–8.PubMed
11.
Bennett JA, Riegel B, Bittner V, Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & lung : the journal of critical care. 2002;31(4):262–70.
12.
Lim FY, Yap J, Gao F, Teo LL, Lam CSP, Yeo KK. Correlation of the New York heart association classification and the cardiopulmonary exercise test: a systematic review. Int J Cardiol. 2018;263:88–93.PubMed
13.
Russell SD, Saval MA, Robbins JL, Ellestad MH, Gottlieb SS, Handberg EM, Zhou Y, Chandler B. New York heart association functional class predicts exercise parameters in the current era. Am Heart J. 2009;158(4 Suppl):S24–30.PubMedPubMedCentral
14.
Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Levin-Iaina N, Iaina A, Dobrzycki S. Prevalence of chronic kidney disease and anemia in patients with coronary artery disease with normal serum creatinine undergoing percutaneous coronary interventions: relation to New York heart association class. The Israel Medical Association journal : IMAJ. 2010;12(8):489–93.PubMed
15.
Holland R, Rechel B, Stepien K, Harvey I, Brooksby I. Patients' self-assessed functional status in heart failure by New York heart association class: a prognostic predictor of hospitalizations, quality of life and death. J Card Fail. 2010;16(2):150–6.PubMedPubMedCentral
16.
Koren-Morag N, Goldbourt U, Tanne D. Poor functional status based on the New York heart association classification exposes the coronary patient to an elevated risk of ischemic stroke. Am Heart J. 2008;155(3):515–20.PubMed
17.
Asano R, Kajimoto K, Oka T, Sugiura R, Okada H, Kamishima K, Hirata T, Sato N. Association of new York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes. Int J Cardiol. 2017;230:585–91.PubMed
18.
de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the heart and soul study. Psychosom Med. 2007;69(8):735–9.PubMedPubMedCentral
19.
Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS. The Association of Cognitive and Somatic Depressive Symptoms with Depression Recognition and outcomes after myocardial infarction. Circulation Cardiovascular Quality & Outcomes. 2009;2(4):328.
20.
de Miranda Azevedo R, Roest AM, Hoen PW, de Jonge P. Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med. 2014;44(13):2689–703.PubMed
21.
Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, de Jonge P. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol. 2010;56(11):838–44.PubMedPubMedCentral
22.
Schiffer AA, Pelle AJ, Smith OR, Widdershoven JW, Hendriks EH, Pedersen SS. Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. The Journal of clinical psychiatry. 2009;70(12):1667–73.PubMed
23.
Braunwald E. Unstable angina. A classification. Circulation. 1989;80(2):410–4.PubMed
24.
Kroenke K, Spitzer RL. The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann. 2002;32(9):509–21.
25.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.PubMedPubMedCentral
26.
Bhatt KN, Kalogeropoulos AP, Dunbar SB, Butler J, Georgiopoulou VV. Depression in heart failure: can PHQ-9 help? Int J Cardiol. 2016;221:246–50.PubMed
27.
Zhu Y, Blumenthal JA, Shi C, Jiang R, Patel A, Zhang A, Yu X, Gao R. Wu Y: sedentary behavior and the risk of depression in patients with acute coronary syndromes. Am J Cardiol. 2018;121(12):1456–60.PubMed
28.
Baas KD, Cramer AO, Koeter MW, Eh VDL, van Weert HC, Schene AH. Measurement invariance with respect to ethnicity of the patient health Questionnaire-9 (PHQ-9). J Affect Disord. 2011;129(1–3):229.PubMed
29.
Krause JS, Bombardier C, Carter RE. Assessment of depressive symptoms during inpatient rehabilitation for spinal cord injury: is there an underlying somatic factor when using the PHQ? Rehabilitation Psychology. 2008;27(53):513–20.
30.
Krause JS, Reed KS, Mcardle JJ. Factor structure and predictive validity of somatic and nonsomatic symptoms from the patient health questionnaire-9: a longitudinal study after spinal cord injury. Archives of Physical Medicine & Rehabilitation. 2010;91(8):1218–24.
31.
Hawkins MA, Dolansky MA, Schaefer JT, Fulcher MJ, Gunstad J, Redle JD, Josephson R, Hughes JW. Cognitive function in heart failure is associated with nonsomatic symptoms of depression but not somatic symptoms. The Journal of cardiovascular nursing. 2015;30(5):E9–e17.PubMedPubMedCentral
32.
Elhai JD, Contractor AA, Tamburrino M, Fine TH, Prescott MR, Shirley E, Chan PK, Slembarski R, Liberzon I, Galea S. The factor structure of major depression symptoms: a test of four competing models using the patient health Questionnaire-9. Psychiatry Res. 2012;199(3):169–73.PubMed
33.
Petersen JJ, Paulitsch MA, Hartig J, Mergenthal K, Gerlach FM, Gensichen J. Factor structure and measurement invariance of the patient health Questionnaire-9 for female and male primary care patients with major depression in Germany. J Affect Disord. 2015;170:138–42.PubMed
34.
Richardson EJ, Richards JS. Factor structure of the PHQ-9 screen for depression across time since injury among persons with spinal cord injury. Rehabilitation Psychology. 2008;53(2):243–9.
35.
Hu Lt BPM. Cutoff criteria for fit indexes in covariance structure Anaysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6(1):1–55.
36.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMed
37.
Sawaya H, Atoui M, Hamadeh A, Zeinoun P, Nahas Z. Adaptation and initial validation of the patient health questionnaire - 9 (PHQ-9) and the generalized anxiety disorder - 7 questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–52.PubMed
38.
WANG Li LK, WANG Changying, SHENG Li, HU Dayi, DING Rongjing: Reliability and validity of GAD-2 and GAD-7 for anxiety screening in cardiovascular disease clinic. Sichuan Mental Health 2014, 27(3):198–201.
39.
Hinz A, Klein AM, Brahler E, Glaesmer H, Luck T, Riedel-Heller SG, Wirkner K, Hilbert A. Psychometric evaluation of the generalized anxiety disorder screener GAD-7, based on a large German general population sample. J Affect Disord. 2017;210:338–44.PubMed
40.
Suzuki T, Shiga T, Kuwahara K, Kobayashi S, Suzuki S, Nishimura K, Suzuki A, Omori H, Mori F, Ishigooka J, et al. Depression and outcomes in hospitalized Japanese patients with cardiovascular disease. - prospective single-center observational study. Circulation journal : official journal of the Japanese Circulation Society. 2011;75(10):2465–73.
41.
Faller H, Steinbuchel T, Stork S, Schowalter M, Ertl G, Angermann CE. Impact of depression on quality of life assessment in heart failure. Int J Cardiol. 2010;142(2):133–7.PubMed
42.
Brouwers C, Kupper N, Pelle AJ, Szabo BM, Westerhuis BL, Denollet J. Depressive symptoms in outpatients with heart failure: importance of inflammatory biomarkers, disease severity and personality. Psychology & health. 2014;29(5):564–82.
43.
Sokoreli I, de Vries JJ, Riistama JM, Pauws SC, Steyerberg EW, Tesanovic A, Geleijnse G, Goode KM, Crundall-Goode A, Kazmi S, et al. Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. Int J Cardiol. 2016;220:202–7.PubMed
44.
Assari S, Zandi H, Ahmadi K, Kazemi Saleh D. Extent of coronary stenosis and anxiety symptoms among patients undergoing coronary angiography. The journal of Tehran Heart Center. 2017;12(4):155–9.PubMedPubMedCentral
45.
Vaccarino V, Sullivan S, Hammadah M, Wilmot K, Al Mheid I, Ramadan R, Elon L, Pimple PM, Garcia EV, Nye J, et al. Mental stress-induced-myocardial ischemia in Young patients with recent myocardial infarction: sex differences and mechanisms. Circulation. 2018;137(8):794–805.PubMedPubMedCentral
46.
Smolderen KG, Spertus JA, Gosch K, Dreyer RP, D'Onofrio G, Lichtman JH, Geda M, Beltrame J, Safdar B, Bueno H, et al. Depression treatment and health status outcomes in Young patients with acute myocardial infarction: insights from the VIRGO study (variation in recovery: role of gender on outcomes of Young AMI patients). Circulation. 2017;135(18):1762–4.PubMedPubMedCentral
47.
Kim JM, Stewart R, Lee YS, Lee HJ, Kim MC, Kim JW, Kang HJ, Bae KY, Kim SW, Shin IS, et al. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. Jama. 2018;320(4):350–8.PubMed
48.
Yost G, Bhat G, Mahoney E, Tatooles A. Reduced anxiety and depression in patients with advanced heart failure after left ventricular assist device implantation. Psychosomatics. 2017;58(4):406–14.PubMed
49.
O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol. 2010;56(9):692–9.PubMedPubMedCentral
50.
Angermann CE, Gelbrich G, Stork S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, et al. Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. Jama. 2016;315(24):2683–93.PubMed
Metadata
Title
Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study
Authors
Han Yin
Yuting Liu
Huan Ma
Guihao Liu
Lan Guo
Qingshan Geng
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2061-3

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue

Research article

Exploring mental health professionals’ practice in relation to smoke-free policy within a mental health trust: a qualitative study using the COM-B model of behaviour

Case report

A case report of the successful administration of clozapine in the face of myocardial infarction, pulmonary embolism and hyperlipidaemia resulting in the termination of long-term seclusion

Study protocol

The GET READY relapse prevention programme for anxiety and depression: a mixed-methods study protocol

Research article

Cognitive insight and quality of life among psychiatric outpatients

Research article

Prepulse inhibition in patients with bipolar disorder: a systematic review and meta-analysis

Study protocol

Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial